Russell Microcap Index

Quipt Home Medical on Preliminary List to Join Russell 2000® and 3000® Indexes

Retrieved on: 
Tuesday, May 23, 2023

Updates are provided by the Russell Microcap Index on May 26, June 2, June 9, June 16 and June 23.

Key Points: 
  • Updates are provided by the Russell Microcap Index on May 26, June 2, June 9, June 16 and June 23.
  • Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, 2023, ranking them by total market capitalization.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.
  • For more information on the Russell 2000® and 3000® Indexes and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website .

Data I/O Set to Join Russell Microcap Index

Retrieved on: 
Thursday, May 25, 2023

Data I/O Corporation (NASDAQ: DAIO), the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced it is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market closes on June 23rd, according to a preliminary list of additions posted May 19.

Key Points: 
  • Data I/O Corporation (NASDAQ: DAIO), the leading global provider of advanced security and data deployment solutions for microcontrollers, security ICs and memory devices, today announced it is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market closes on June 23rd, according to a preliminary list of additions posted May 19.
  • Membership in the Russell Microcap Index, which remains in place for one year, results in automatic inclusion in any growth and value style funds or other portfolios modeled after the index.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.
  • Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.

Loop Media set to join Russell 2000®, Russell 3000® and Russell Microcap Indexes

Retrieved on: 
Tuesday, May 23, 2023

Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization.

Key Points: 
  • Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • “This is a significant moment for everyone associated with Loop Media to be selected to join the Russell 2000, 3000 and Microcap Indexes within our first year of being listed on the NYSE American,” said Jon Niermann, CEO and Co-Founder of Loop Media.
  • For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website .

180 Degree Capital Corp. Notes $6.52 Net Asset Value per Share as of March 31, 2023 and $5 Million Reauthorized Share Repurchase Program

Retrieved on: 
Thursday, May 11, 2023

“As noted in our release on April 1, 2023, Q1 2023 was a positive quarter for 180,” said Kevin M. Rendino, Chief Executive Officer of 180.

Key Points: 
  • “As noted in our release on April 1, 2023, Q1 2023 was a positive quarter for 180,” said Kevin M. Rendino, Chief Executive Officer of 180.
  • “Our +5.7% gross total return of our public and public-related portfolio compared favorably to the -2.9% total return of the Russell Microcap Index.
  • Our increase in NAV of 3.2% to $6.52 reflects this increase, offset by a small decline in our privately held portfolio.
  • Unfortunately, the 4.7% decline in our stock price during the quarter expanded this discount, and it increased further during Q2 2023.

180 Degree Capital Corp. Reports +5.7% Gross Total Return in Public and Related Portfolio in Q1 2023

Retrieved on: 
Monday, April 3, 2023

Cash and Securities of Public and Related Companies as of March 31, 2023, Currently Expected at Close to 90 Percent of Net Asset Value Per Share

Key Points: 
  • Cash and Securities of Public and Related Companies as of March 31, 2023, Currently Expected at Close to 90 Percent of Net Asset Value Per Share
    MONTCLAIR, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported preliminary results of its public and related portfolio as of March 31, 2023.
  • “We are pleased to report a +5.7% gross total return in our public and related portfolio for the first quarter of 2023,” said Kevin M. Rendino, Chief Executive Officer of 180.
  • “This performance compares favorably to the -2.9% total return of the Russell Microcap Index.
  • While it remains early in 2023, and risks abound, we are encouraged with our performance during Q1 2023.

180 Degree Capital Corp. Notes $7.08 Approximate NAV, or an Increase of 12.0%, as of February 23, 2023, Resulting From a +14.8% Gross Total Return of Its Public Portfolio

Retrieved on: 
Monday, February 27, 2023

“The gross total return of our public and related holdings from the end of 2022 through February 23, 2023, of approximately 14.8% has further reduced the percentage of our legacy private holding percentage of NAV to approximately 12%2.

Key Points: 
  • “The gross total return of our public and related holdings from the end of 2022 through February 23, 2023, of approximately 14.8% has further reduced the percentage of our legacy private holding percentage of NAV to approximately 12%2.
  • This performance compares favorably to the overall public markets, including the total return of the Russell Microcap Index of 7.0%.
  • The call can be accessed by phone at (609) 746-1082 passcode 415049 or via the web at https://www.freeconferencecall.com/wall/180degreecapital .
  • Additionally, slides that will be referred to during the presentation can be found on 180’s investor relations website at https://ir.180degreecapital.com/ir-calendar .

Broadwind Confirms Receipt of WM Argyle Fund’s Notice of Intent to Nominate Directors at the 2023 Annual Meeting

Retrieved on: 
Thursday, January 19, 2023

Broadwind believes that the Fund’s attempt to take over Broadwind’s full Board represents a disguised attempt to seize control of the Company without paying a premium.

Key Points: 
  • Broadwind believes that the Fund’s attempt to take over Broadwind’s full Board represents a disguised attempt to seize control of the Company without paying a premium.
  • However, Broadwind remains committed to maintaining an open dialogue while continuing to represent the best interests of all stockholders.
  • Moreover, 80% of the Company’s directors are independent, ensuring objectivity and proper representation of all stockholder interests.
  • The date of the 2023 Annual Meeting will be announced in due course.

Quipt Home Medical Reports Ongoing Operational Strength With Record Third Quarter Fiscal 2022 Financial Results

Retrieved on: 
Monday, August 15, 2022

CINCINNATI, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the Company) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its third quarter fiscal 2022 financial results and operational highlights.

Key Points: 
  • CINCINNATI, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the Company) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its third quarter fiscal 2022 financial results and operational highlights.
  • Compared to 133,704 unique set-ups/deliveries in Q3 2022, the Company completed 95,192 unique set-ups/deliveries in Q3 2021, an increase of 40%.
  • The robust financial and operating results in the fiscal third quarter are reflective of the continued operational excellence displayed throughout each facet of the organization.
  • Chief Financial Officer Hardik Mehta added, Our record fiscal third quarter results demonstrate our ability to successfully operate the business through a challenging operating environment.

Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

Retrieved on: 
Thursday, August 11, 2022

PHILADELPHIA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc., (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today reported financial results and business highlights for the second quarter ended June 30, 2022.

Key Points: 
  • Additionally, we look forward to providing updates on our gamma delta iT platform and other program advancements in the coming months.
  • Century expects to submit an Investigational New Drug (IND) application for CNTY-103 in 2024.
  • Century was added to the Russell Microcap Index in June 2022.
  • We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations.

180 Degree Capital Corp. Reports Preliminary Q2 2022 Net Asset Value Per Share Decline Of 14.5-15.0% From Q1 2022 Net Asset Value Per Share Of $9.81

Retrieved on: 
Thursday, July 14, 2022

We currently expect net asset value per share (NAV) as of the end of Q2 2022 will decline by 14.5-15.0% to approximately $8.30-8.35 per share.

Key Points: 
  • We currently expect net asset value per share (NAV) as of the end of Q2 2022 will decline by 14.5-15.0% to approximately $8.30-8.35 per share.
  • This expected decline in NAV is less than the 19% decline of the Russell Microcap Index.
  • We purposefully kept our cash balances elevated, and the preliminary decline of our legacy private holdings was approximately 3.3%.
  • While never happy with a decline in our NAV, our quarter decline and year to date decline was less severe than the Russell Microcap Index decline for the same periods.